IIPM Best B-School
Despite the challenges in accessing investment, funding opportunities for biotechnology companies have increased dramatically in recent years as venture capitalists in Spain have learned more about the sector, and as companies start to mature and attract investment from outside the country. Many companies describe recent large-scale investments from Europe.
Genetrix is initiating the first venture capital fund specializing in biomedicine, named Vanguardia BioFund 1. It expects to fund startups and expanding companies, with about 70 percent of the investments to flow to Spanish companies.
In terms of management, the latest crop of CEOs now have years of experience and are beginning to bring their know-how to a new generation of startups. In addit ion, the inf rast r ucture to support technology transfer is growing ever stronger thanks to government, academic, and industry commitment, both on a national and a regional level.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2007
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
For More IIPM Article, Visit Below....
http://iipm-top-mba-institute.spaces.live.com/
http://iipm-here-is-your-future.spaces.live.com/
http://iipm-campus-events.spaces.live.com/
http://iipm-institute.spaces.live.com/
Friday, June 01, 2007
Taking on the Challenges
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment